|
Bicalutamide |
|
|
ALX-270-476-M100 |
|
100 mg |
40.00 USD |
|
 |
|
ALX-270-476-M500 |
|
500 mg |
140.00 USD |
|
|
|
ALX-270-476-G001 |
|
1 g |
220.00 USD |
|
|
|
|
(R,S)-Equol |
|
|
ALX-385-032-M005 |
|
5 mg |
30.00 USD |
|
|
|
ALX-385-032-M025 |
|
25 mg |
120.00 USD |
|
|
|
|
SAG |
|
|
ALX-270-426-M001 |
|
1 mg |
195.00 USD |
|
|
|
|
SANT-2 |
|
|
ALX-270-436-M001 |
|
1 mg |
165.00 USD |
|
|
|
|
GANT61 |
|
|
ALX-270-482-M001 |
|
1 mg |
190.00 USD |
|
|
|
|
Tomatidine . hydrochloride |
|
|
ALX-350-377-M025 |
|
25 mg |
45.00 USD |
|
|
|
|
Jervine |
|
|
ALX-350-378-M001 |
|
1 mg |
90.00 USD |
|
|
|
ALX-350-378-M005 |
|
5 mg |
360.00 USD |
|
|
|
|
Purmorphamine |
|
|
ALX-420-045-M001 |
|
1 mg |
40.00 USD |
|
|
|
ALX-420-045-M005 |
|
5 mg |
145.00 USD |
|
|
|
ALX-420-045-M025 |
|
25 mg |
510.00 USD |
|
|
|
|
Cyclopamine |
|
|
ALX-430-159-M001 |
|
1 mg |
80.00 USD |
|
|
|
ALX-430-159-M005 |
|
5 mg |
320.00 USD |
|
|
|
|
pro-β-Nerve Growth Factor (human) (recombinant) |
|
|
ALX-201-207-C020 |
|
20 µg |
490.00 USD |
|
|
|
|
β-Nerve Growth Factor (human) (recombinant) |
|
|
ALX-201-208-C020 |
|
20 µg |
190.00 USD |
|
|
|
|
β-Nerve Growth Factor (human) (recombinant) |
|
|
ALX-521-005-C005 |
|
5 µg |
140.00 USD |
|
|
|
|
Nerve Growth Factor 2.5S (mouse) Grade I |
|
|
ALX-521-006-C010 |
|
10 µg |
95.00 USD |
|
|
|
|
Nerve Growth Factor 2.5S (mouse) Grade II |
|
|
ALX-521-007-C025 |
|
25 µg |
180.00 USD |
|
|
|
ALX-521-007-C100 |
|
100 µg |
420.00 USD |
|
|
|
|
Nerve Growth Factor 7S (mouse) |
|
|
ALX-521-008-C100 |
|
100 µg |
245.00 USD |
|
|
|
|
Nerve Growth Factor Receptor (human):Fc (human) (recombinant) |
|
|
ALX-522-044-C050 |
|
50 µg |
360.00 USD |
|
|
|
 |
|
|
RGMA, Soluble (human) (recombinant) |
|
|
ALX-522-103-2010 |
|
2x10 µg |
240.00 USD |
|
|
|
|
RGMC, Soluble (human) (recombinant) |
|
|
ALX-522-104-C010 |
|
10 µg |
290.00 USD |
|
|
|
|
RGMA, Soluble (mouse) (recombinant) |
|
|
ALX-522-134-2010 |
|
2x10 µg |
240.00 USD |
|
|
|
|
RGMB, Soluble (human) (recombinant) |
|
|
ALX-522-139-C010 |
|
10 µg |
300.00 USD |
|
|
|
